Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 financial results
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today.
Reported sales increased 2.4% year-over-year to $21.9 billion. Operational sales growth was 4.2%.
Net earnings rose to $11 billion, or $4.54 per share, from $3.25 billion, or $1.34 per share, last year. Adjusted EPS grew 2.2% to $2.77.
Revenue and earnings beat estimates.
The company raised its sales outlook for the full year of 2025 and now expects reported sales of $91.0-91.8 billion. Adjusted EPS guidance remains unchanged at $10.50-10.70.
JNJ also declared a 4.8% increase in its quarterly dividend, from $1.24 per share to $1.30 per share. The stock was down in premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
